GlassScriptPhysician profile
Georges M Argoud
NPI 1144303538
$3,442.29
in general payments reported to CMS, 2019-2025
37 companies · $1,393 in 2025
The $1,393 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2020: $121 · 2021: $194 · 2022: $298 · 2023: $435 · 2024: $750 · 2025: $1,393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,486 · Education: $92.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,486.15 |
| Education | $92.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $322.49 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Insulet Corporation | $268.15 | 2024-2025 | Omnipod |
| Amgen INC. | $260.94 | 2023-2025 | Tepezza, Evenity, Prolia |
| Cequr Corporation | $255.68 | 2022-2025 | Cequr Simplicity |
| Sanofi-Aventis U.S. LLC | $245.72 | 2019-2025 | |
| Horizon Therapeutics Plc | $229.33 | 2019-2023 | Tepezza |
| Recordati_rare_diseases_inc. | $184.08 | 2023-2025 | Isturisa, Signifor Lar |
| Abbott Laboratories | $142.78 | 2019-2025 | Freestyle Libre 3 |
| Valeritas, INC. | $136.02 | 2019 | |
| Tandem Diabetes Care, INC. | $124.94 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Radius Health, INC. | $121.36 | 2022-2025 | |
| Dexcom, INC. | $119.28 | 2019-2025 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $112.92 | 2024-2025 | Gvoke Hypopen, Recorlev |
| Astrazeneca Pharmaceuticals LP | $110.99 | 2020-2023 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $89.48 | 2022-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $83.08 | 2021-2025 | Minimed 780g |
| Beta Bionics, INC. | $79.43 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Mannkind Corporation | $75.47 | 2021-2025 | |
| Sequel Med Tech, LLC | $62.60 | 2025 | Twiist |
| Ascendis Pharma Endocrinology INC | $52.95 | 2025 | Yorvipath |
| Currax Pharmaceuticals LLC | $50.00 | 2023 | Nexletol |
| Nevro Corp. | $38.18 | 2024 | Senza |
| Almatica Pharma LLC | $29.53 | 2025 | Teriparatide |
| Corcept Therapeutics | $28.48 | 2025 | Korlym |
| Novo Nordisk INC | $28.23 | 2021-2022 | |
| Rhythm Pharmaceuticals, INC. | $28.05 | 2025 | Imcivree |
| Janssen Pharmaceuticals, INC | $24.94 | 2019-2020 | |
| Chiesi USA, INC. | $21.32 | 2025 | Mycapssa |
| Novartis Pharmaceuticals Corporation | $20.75 | 2022 | |
| Medtronic Minimed, INC. | $18.49 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.25 | 2025 | Jardiance |
| Tolmar, INC. | $15.56 | 2025 | Jatenzo |
| Ascensia Diabetes Care US INC. | $15.53 | 2024 | |
| Verity Pharmaceuticals INC. | $15.10 | 2024 | Tlando |
| Kyowa Kirin, INC. | $14.19 | 2025 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Georges Argoud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.